Pacira BioSciences Inc (PCRX)
14.54
+0.21
(+1.47%)
USD |
NASDAQ |
Sep 27, 16:00
14.52
-0.02
(-0.14%)
After-Hours: 20:00
Pacira BioSciences 30-Day Average Daily Volume: 1.146M for Sept. 27, 2024
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 27, 2024 | 1.146M |
| September 26, 2024 | 1.186M |
| September 25, 2024 | 1.226M |
| September 24, 2024 | 1.329M |
| September 23, 2024 | 1.518M |
| September 20, 2024 | 1.588M |
| September 19, 2024 | 1.463M |
| September 18, 2024 | 1.467M |
| September 17, 2024 | 1.473M |
| September 16, 2024 | 1.459M |
| September 13, 2024 | 1.425M |
| September 12, 2024 | 1.420M |
| September 11, 2024 | 1.436M |
| September 10, 2024 | 1.435M |
| September 09, 2024 | 1.425M |
| September 06, 2024 | 1.420M |
| September 05, 2024 | 1.440M |
| September 04, 2024 | 1.465M |
| September 03, 2024 | 1.452M |
| August 30, 2024 | 1.460M |
| August 29, 2024 | 1.472M |
| August 28, 2024 | 1.494M |
| August 27, 2024 | 1.503M |
| August 26, 2024 | 1.530M |
| August 23, 2024 | 1.550M |
| Date | Value |
|---|---|
| August 22, 2024 | 1.547M |
| August 21, 2024 | 1.544M |
| August 20, 2024 | 1.546M |
| August 19, 2024 | 1.541M |
| August 16, 2024 | 1.529M |
| August 15, 2024 | 1.519M |
| August 14, 2024 | 1.492M |
| August 13, 2024 | 1.736M |
| August 12, 2024 | 1.616M |
| August 09, 2024 | 1.464M |
| August 08, 2024 | 1.370M |
| August 07, 2024 | 1.379M |
| August 06, 2024 | 1.369M |
| August 05, 2024 | 1.363M |
| August 02, 2024 | 1.410M |
| August 01, 2024 | 1.403M |
| July 31, 2024 | 1.411M |
| July 30, 2024 | 1.387M |
| July 29, 2024 | 1.374M |
| July 26, 2024 | 1.371M |
| July 25, 2024 | 1.367M |
| July 24, 2024 | 1.341M |
| July 23, 2024 | 1.317M |
| July 22, 2024 | 1.301M |
| July 19, 2024 | 1.275M |
30-Day Average Daily Volume Range, Past 5 Years
320920.1
Minimum
Aug 09 2021
1.736M
Maximum
Aug 13 2024
580332.1
Average
515308.5
Median
30-Day Average Daily Volume Benchmarks
| Amgen Inc | 1.915M |
| Biogen Inc | 957210.1 |
| Gilead Sciences Inc | 6.952M |
| Merck & Co Inc | 9.058M |
| Revance Therapeutics Inc | 5.143M |